Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-04

Clinical Trial Update: Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy [NA]

View source ↗

Summary

This clinical trial is evaluating hilotherapy as a preventive treatment for chemotherapy-induced peripheral neuropathy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hilotherapy device

Snippet

Sponsor: University of Ulm | Conditions: Equipment and Supplies | NA | Status: RECRUITING